Thinking Flexibly in Biomanufacturing
Single-use systems may offer a suitably flexible solution to the biomanufacturing challenges of cost and time-to-market.
The global biopharmaceutical market is set to grow by a compound annual growth rate of nearly 14% over the next six years, according to market research. Reported drivers for this progression include an aging global population, an increase in the prevalence of chronic conditions, and an overall rise in the uptake of biopharmaceutical products on the global market.
In this article, the benefits, evolution, and limitations of single-use systems in biomanufacturing are explored.
Read this article in BioPharm International's Single-Use Systems 2019 eBook.
Article Details
BioPharm International
eBook: Single-Use Systems 2019
June 2019
Pages: 4–8
Citation
When referring to this article, please cite it as F. Thomas, "Thinking Flexibly in Biomanufacturing," BioPharm International's Single-Use Systems eBook (June 2019).
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
